Libutti SK - Search Results

1

Modulation of tumor-host interactions, angiogenesis, and tumor growth by tissue inhibitor of metalloproteinase 2 via a novel mechanism.

Feldman AL, Stetler-Stevenson WG, Costouros NG, Knezevic V, Baibakov G, Alexander HR Jr, Lorang D, Hewitt SM, Seo DW, Miller MS, O'Connor S, Libutti SK. Feldman AL, et al. Among authors: libutti sk. Cancer Res. 2004 Jul 1;64(13):4481-6. doi: 10.1158/0008-5472.CAN-03-2929. Cancer Res. 2004. PMID: 15231657

2

Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma.

Feldman AL, Alexander HR Jr, Yang JC, Linehan WM, Eyler RA, Miller MS, Steinberg SM, Libutti SK. Feldman AL, et al. Among authors: libutti sk. Cancer. 2002 Oct 15;95(8):1637-43. doi: 10.1002/cncr.10845. Cancer. 2002. PMID: 12365010 Free article.

3

Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism.

Libutti SK, Crabtree JS, Lorang D, Burns AL, Mazzanti C, Hewitt SM, O'Connor S, Ward JM, Emmert-Buck MR, Remaley A, Miller M, Turner E, Alexander HR, Arnold A, Marx SJ, Collins FS, Spiegel AM. Libutti SK, et al. Cancer Res. 2003 Nov 15;63(22):8022-8. Cancer Res. 2003. PMID: 14633735

4

Using gene expression profiling to differentiate benign versus malignant thyroid tumors.

Mazzanti C, Zeiger MA, Costouros NG, Umbricht C, Westra WH, Smith D, Somervell H, Bevilacqua G, Alexander HR, Libutti SK. Mazzanti C, et al. Among authors: libutti sk. Cancer Res. 2004 Apr 15;64(8):2898-903. doi: 10.1158/0008-5472.can-03-3811. Cancer Res. 2004. PMID: 15087409

5

Proadrenomedullin NH2-terminal 20 peptide is a potent angiogenic factor, and its inhibition results in reduction of tumor growth.

Martínez A, Zudaire E, Portal-Núñez S, Guédez L, Libutti SK, Stetler-Stevenson WG, Cuttitta F. Martínez A, et al. Among authors: libutti sk. Cancer Res. 2004 Sep 15;64(18):6489-94. doi: 10.1158/0008-5472.CAN-04-0103. Cancer Res. 2004. PMID: 15374959

6

Functional characterization of filamin a interacting protein 1-like, a novel candidate for antivascular cancer therapy.

Kwon M, Hanna E, Lorang D, He M, Quick JS, Adem A, Stevenson C, Chung JY, Hewitt SM, Zudaire E, Esposito D, Cuttitta F, Libutti SK. Kwon M, et al. Among authors: libutti sk. Cancer Res. 2008 Sep 15;68(18):7332-41. doi: 10.1158/0008-5472.CAN-08-1087. Cancer Res. 2008. PMID: 18794120 Free PMC article.

7

Tumor vasculature-targeted delivery of tumor necrosis factor-alpha.

Tandle A, Hanna E, Lorang D, Hajitou A, Moya CA, Pasqualini R, Arap W, Adem A, Starker E, Hewitt S, Libutti SK. Tandle A, et al. Among authors: libutti sk. Cancer. 2009 Jan 1;115(1):128-39. doi: 10.1002/cncr.24001. Cancer. 2009. PMID: 19090007 Free PMC article.

8

Retroviral gene transfer of interferon-inducible protein 10 inhibits growth of human melanoma xenografts.

Feldman AL, Friedl J, Lans TE, Libutti SK, Lorang D, Miller MS, Turner EM, Hewitt SM, Alexander HR. Feldman AL, et al. Among authors: libutti sk. Int J Cancer. 2002 May 1;99(1):149-53. doi: 10.1002/ijc.10292. Int J Cancer. 2002. PMID: 11948506

9

Adenovirus-mediated endostatin delivery results in inhibition of mammary gland tumor growth in C3(1)/SV40 T-antigen transgenic mice.

Calvo A, Feldman AL, Libutti SK, Green JE. Calvo A, et al. Among authors: libutti sk. Cancer Res. 2002 Jul 15;62(14):3934-8. Cancer Res. 2002. PMID: 12124322

10

Molecular imaging of tumor angiogenesis.

Costouros NG, Diehn FE, Libutti SK. Costouros NG, et al. Among authors: libutti sk. J Cell Biochem Suppl. 2002;39:72-8. doi: 10.1002/jcb.10426. J Cell Biochem Suppl. 2002. PMID: 12552605 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters